食药监总局加强互联网药品医疗器械监管,强化投诉举报处理

2017-11-02 佚名 国家食品药品监督管理总局网站

总局办公厅关于加强互联网药品医疗器械交易监管工作的通知食药监办法〔2017〕144号2017年11月02日 发布各省、自治区、直辖市食品药品监督管理局,新疆生产建设兵团食品药品监督管理局:为贯彻落实《国务院关于取消一批行政许可事项的决定》(国发〔2017〕46号)的要求,做好相关事中事后监管措施的衔接工作,现就加强互联网药品、医疗器械交易监管工作有关事项通知如下:一、落实监管责任。建立完善互联网药

总局办公厅关于加强互联网药品医疗器械交易监管工作的通知

食药监办法〔2017〕144号

2017年11月02日 发布

各省、自治区、直辖市食品药品监督管理局,新疆生产建设兵团食品药品监督管理局:

为贯彻落实《国务院关于取消一批行政许可事项的决定》(国发〔2017〕46号)的要求,做好相关事中事后监管措施的衔接工作,现就加强互联网药品、医疗器械交易监管工作有关事项通知如下:

一、落实监管责任。建立完善互联网药品、医疗器械交易服务企业(第三方)监管制度,按照“线上线下一致”原则,规范互联网药品、医疗器械交易行为。各地应按属地原则将平台网站纳入省级食品药品监管部门日常监督检查范围,监督平台企业落实入驻审查、产品检查、交易数据保存、配合检查等义务和责任,及时处理违法违规行为。

二、加大监督检查力度。各省级食品药品监管部门应将有互联网药品、医疗器械经营行为的企业列入重点检查对象,以互联网监测和投诉举报信息为重点线索,开展专项监督检查,查处利用互联网非法售药、经营医疗器械以及提供不真实互联网药品、医疗器械信息服务等违法违规行为。

三、强化投诉举报处理。各地食品药品监管部门要结合本地实际,广泛利用政府网站、微博、微信公众号等媒体加大网购药品、医疗器械安全等问题的警示宣传,引导公众正确消费;畅通网络、电话等投诉举报渠道,对查实的违法违规问题依法及时处理,并及时回复举报人。

四、严厉打击违法行为。各地食品药品监管部门应联合有关部门和单位探索建立互联网药品、医疗器械违法犯罪线索排查、违法认定、证据固定、依法查处的有效机制,继续加大对利用互联网非法制售药品、医疗器械等违法行为的打击力度。

五、大力推进信息公开。各地食品药品监管部门对办理的行政处罚案件的信息及时公开。

六、强化监管有效衔接。自《国务院关于取消一批行政许可事项的决定》(国发〔2017〕46号)发布之日起,总局不再受理互联网药品交易服务企业(第三方)审批的申请;发布之日前总局已受理的,将终止审批,并将申请材料退还申请人。省级食品药品监管部门应抓紧做好取消行政许可事项的衔接工作。

七、督促监管责任落实。总局将对各省级食品药品监管部门互联网药品、医疗器械交易监管责任落实情况进行经常性检查,并公开监督结果。

国发〔2017〕46号文件公布取消的药用辅料注册(新药用辅料和进口药用辅料注册)审批、直接接触药品的包装材料和容器审批以及医疗器械临床试验机构资格认定等三项行政许可事项的事中事后监管措施,总局将另行发布。

食品药品监管总局办公厅

2017年11月1日

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2076240, encodeId=d97920e624033, content=<a href='/topic/show?id=b4351011422b' target=_blank style='color:#2F92EE;'>#食药监#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101142, encryptionId=b4351011422b, topicName=食药监)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Thu May 10 05:17:00 CST 2018, time=2018-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1705884, encodeId=38341e05884ea, content=<a href='/topic/show?id=76e510114468' target=_blank style='color:#2F92EE;'>#食药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101144, encryptionId=76e510114468, topicName=食药监总局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a73b31099952, createdName=lilili1114, createdTime=Sun Jun 17 17:17:00 CST 2018, time=2018-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840435, encodeId=8df6184043567, content=<a href='/topic/show?id=186b8e937c6' target=_blank style='color:#2F92EE;'>#药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87937, encryptionId=186b8e937c6, topicName=药监总局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19ad38, createdName=lq1767, createdTime=Thu Jul 26 16:17:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274120, encodeId=dd1e12e4120d8, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Sat Nov 04 13:17:00 CST 2017, time=2017-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1371495, encodeId=656513e1495cb, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72339, encryptionId=bf1ce2339d0, topicName=监管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b96f328, createdName=wwzzly, createdTime=Sat Nov 04 13:17:00 CST 2017, time=2017-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591123, encodeId=65961591123f8, content=<a href='/topic/show?id=89135502004' target=_blank style='color:#2F92EE;'>#投诉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55020, encryptionId=89135502004, topicName=投诉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ecd17916371, createdName=appleandpeer, createdTime=Sat Nov 04 13:17:00 CST 2017, time=2017-11-04, status=1, ipAttribution=)]
    2018-05-10 cmsvly
  2. [GetPortalCommentsPageByObjectIdResponse(id=2076240, encodeId=d97920e624033, content=<a href='/topic/show?id=b4351011422b' target=_blank style='color:#2F92EE;'>#食药监#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101142, encryptionId=b4351011422b, topicName=食药监)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Thu May 10 05:17:00 CST 2018, time=2018-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1705884, encodeId=38341e05884ea, content=<a href='/topic/show?id=76e510114468' target=_blank style='color:#2F92EE;'>#食药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101144, encryptionId=76e510114468, topicName=食药监总局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a73b31099952, createdName=lilili1114, createdTime=Sun Jun 17 17:17:00 CST 2018, time=2018-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840435, encodeId=8df6184043567, content=<a href='/topic/show?id=186b8e937c6' target=_blank style='color:#2F92EE;'>#药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87937, encryptionId=186b8e937c6, topicName=药监总局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19ad38, createdName=lq1767, createdTime=Thu Jul 26 16:17:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274120, encodeId=dd1e12e4120d8, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Sat Nov 04 13:17:00 CST 2017, time=2017-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1371495, encodeId=656513e1495cb, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72339, encryptionId=bf1ce2339d0, topicName=监管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b96f328, createdName=wwzzly, createdTime=Sat Nov 04 13:17:00 CST 2017, time=2017-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591123, encodeId=65961591123f8, content=<a href='/topic/show?id=89135502004' target=_blank style='color:#2F92EE;'>#投诉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55020, encryptionId=89135502004, topicName=投诉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ecd17916371, createdName=appleandpeer, createdTime=Sat Nov 04 13:17:00 CST 2017, time=2017-11-04, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2076240, encodeId=d97920e624033, content=<a href='/topic/show?id=b4351011422b' target=_blank style='color:#2F92EE;'>#食药监#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101142, encryptionId=b4351011422b, topicName=食药监)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Thu May 10 05:17:00 CST 2018, time=2018-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1705884, encodeId=38341e05884ea, content=<a href='/topic/show?id=76e510114468' target=_blank style='color:#2F92EE;'>#食药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101144, encryptionId=76e510114468, topicName=食药监总局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a73b31099952, createdName=lilili1114, createdTime=Sun Jun 17 17:17:00 CST 2018, time=2018-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840435, encodeId=8df6184043567, content=<a href='/topic/show?id=186b8e937c6' target=_blank style='color:#2F92EE;'>#药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87937, encryptionId=186b8e937c6, topicName=药监总局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19ad38, createdName=lq1767, createdTime=Thu Jul 26 16:17:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274120, encodeId=dd1e12e4120d8, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Sat Nov 04 13:17:00 CST 2017, time=2017-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1371495, encodeId=656513e1495cb, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72339, encryptionId=bf1ce2339d0, topicName=监管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b96f328, createdName=wwzzly, createdTime=Sat Nov 04 13:17:00 CST 2017, time=2017-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591123, encodeId=65961591123f8, content=<a href='/topic/show?id=89135502004' target=_blank style='color:#2F92EE;'>#投诉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55020, encryptionId=89135502004, topicName=投诉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ecd17916371, createdName=appleandpeer, createdTime=Sat Nov 04 13:17:00 CST 2017, time=2017-11-04, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2076240, encodeId=d97920e624033, content=<a href='/topic/show?id=b4351011422b' target=_blank style='color:#2F92EE;'>#食药监#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101142, encryptionId=b4351011422b, topicName=食药监)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Thu May 10 05:17:00 CST 2018, time=2018-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1705884, encodeId=38341e05884ea, content=<a href='/topic/show?id=76e510114468' target=_blank style='color:#2F92EE;'>#食药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101144, encryptionId=76e510114468, topicName=食药监总局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a73b31099952, createdName=lilili1114, createdTime=Sun Jun 17 17:17:00 CST 2018, time=2018-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840435, encodeId=8df6184043567, content=<a href='/topic/show?id=186b8e937c6' target=_blank style='color:#2F92EE;'>#药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87937, encryptionId=186b8e937c6, topicName=药监总局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19ad38, createdName=lq1767, createdTime=Thu Jul 26 16:17:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274120, encodeId=dd1e12e4120d8, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Sat Nov 04 13:17:00 CST 2017, time=2017-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1371495, encodeId=656513e1495cb, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72339, encryptionId=bf1ce2339d0, topicName=监管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b96f328, createdName=wwzzly, createdTime=Sat Nov 04 13:17:00 CST 2017, time=2017-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591123, encodeId=65961591123f8, content=<a href='/topic/show?id=89135502004' target=_blank style='color:#2F92EE;'>#投诉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55020, encryptionId=89135502004, topicName=投诉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ecd17916371, createdName=appleandpeer, createdTime=Sat Nov 04 13:17:00 CST 2017, time=2017-11-04, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2076240, encodeId=d97920e624033, content=<a href='/topic/show?id=b4351011422b' target=_blank style='color:#2F92EE;'>#食药监#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101142, encryptionId=b4351011422b, topicName=食药监)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Thu May 10 05:17:00 CST 2018, time=2018-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1705884, encodeId=38341e05884ea, content=<a href='/topic/show?id=76e510114468' target=_blank style='color:#2F92EE;'>#食药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101144, encryptionId=76e510114468, topicName=食药监总局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a73b31099952, createdName=lilili1114, createdTime=Sun Jun 17 17:17:00 CST 2018, time=2018-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840435, encodeId=8df6184043567, content=<a href='/topic/show?id=186b8e937c6' target=_blank style='color:#2F92EE;'>#药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87937, encryptionId=186b8e937c6, topicName=药监总局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19ad38, createdName=lq1767, createdTime=Thu Jul 26 16:17:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274120, encodeId=dd1e12e4120d8, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Sat Nov 04 13:17:00 CST 2017, time=2017-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1371495, encodeId=656513e1495cb, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72339, encryptionId=bf1ce2339d0, topicName=监管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b96f328, createdName=wwzzly, createdTime=Sat Nov 04 13:17:00 CST 2017, time=2017-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591123, encodeId=65961591123f8, content=<a href='/topic/show?id=89135502004' target=_blank style='color:#2F92EE;'>#投诉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55020, encryptionId=89135502004, topicName=投诉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ecd17916371, createdName=appleandpeer, createdTime=Sat Nov 04 13:17:00 CST 2017, time=2017-11-04, status=1, ipAttribution=)]
    2017-11-04 wwzzly
  6. [GetPortalCommentsPageByObjectIdResponse(id=2076240, encodeId=d97920e624033, content=<a href='/topic/show?id=b4351011422b' target=_blank style='color:#2F92EE;'>#食药监#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101142, encryptionId=b4351011422b, topicName=食药监)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Thu May 10 05:17:00 CST 2018, time=2018-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1705884, encodeId=38341e05884ea, content=<a href='/topic/show?id=76e510114468' target=_blank style='color:#2F92EE;'>#食药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101144, encryptionId=76e510114468, topicName=食药监总局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a73b31099952, createdName=lilili1114, createdTime=Sun Jun 17 17:17:00 CST 2018, time=2018-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840435, encodeId=8df6184043567, content=<a href='/topic/show?id=186b8e937c6' target=_blank style='color:#2F92EE;'>#药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87937, encryptionId=186b8e937c6, topicName=药监总局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19ad38, createdName=lq1767, createdTime=Thu Jul 26 16:17:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274120, encodeId=dd1e12e4120d8, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Sat Nov 04 13:17:00 CST 2017, time=2017-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1371495, encodeId=656513e1495cb, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72339, encryptionId=bf1ce2339d0, topicName=监管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b96f328, createdName=wwzzly, createdTime=Sat Nov 04 13:17:00 CST 2017, time=2017-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591123, encodeId=65961591123f8, content=<a href='/topic/show?id=89135502004' target=_blank style='color:#2F92EE;'>#投诉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55020, encryptionId=89135502004, topicName=投诉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ecd17916371, createdName=appleandpeer, createdTime=Sat Nov 04 13:17:00 CST 2017, time=2017-11-04, status=1, ipAttribution=)]

相关资讯

华西医院建立国内医学人工智能研发中心

华西医院建立国内首个医学人工智能研发中心,通过“人工智能技术+互联网”,让基层医疗得到升级。

浙江领跑智慧中医,全国首家互联网国医馆将落地乌镇

近日,记者从浙江嘉兴卫生计生委了解到,由嘉兴市推动建设的嘉兴中医云平台已于10月14日正式上线使用,同日上线的还有悬壶台智能化辨证论治云平台3.0和莲芯堂中医药健康服务平台。作为三大中医药智能化应用平台的技术建设方,浙江省卫生信息学会秘书长、浙江莲芯创始人倪荣倪荣表示,嘉兴中医药信息化建设走在全省甚至全国前列,结合即将开放的乌镇互联网国医馆,未来嘉兴市民在“嘉”门口就能享受到优质的中医药服务。更值

鲁小杰副教授团队荣获2017全国“移动互联创新大赛”一等奖

在10月29日揭晓的2017全国“移动互联创新大赛”决赛上,鲁小杰副教授团队在参赛的数百个团队中杀出重围,获得一等奖。分级诊疗制度对基层医院的诊疗水平提出了更高的要求,而医学图像处理是一门专业性高、技术难度较大的学科。部分基层社区医院尚未引进先进的医学图像处理系统,使得部分疾病诊断不能达到精确的水准。如能研发出方便实用的医学图像处理技术,将为基层医疗机构节省了相关设备购置的费用,并且会提高图像辨识

互联网医疗现身“五年成就展”

近日,北京展览馆举行“砥砺奋进的五年”大型成就展,展览期间,全国18个优秀的互联网应用,作为改善人民生活的重要成就进行了展示, 好大夫在线作为互联网医疗领域唯一的受邀企业,与微信、京东、滴滴出行等18个应用一起,展示了互联网在百姓生活的各个领域带来的便捷和高效。9月25日,党和国家领导人前往北京展览馆进行了参观。

内蒙古推“互联网+”药品配送

近日,内蒙古自治区制定出台《关于进一步改革完善药品生产流通使用政策的实施意见》,提出支持药品流通企业与互联网企业加强合作,取消“互联网药品交易服务企业审批”行政许可事项。

世界首例!南非研究人员实现人脑与互联网连接

南非金山大学的研究人员已经成功将一个人的大脑直接连接到互联网。从这个项目获取的数据将直接推动人工智能学习和脑机接口的发展……